The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

21 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Active site-directed plasmin inhibitors: Extension on the P2 residue.EBI
Kobe Gakuin University
Formosusin A, a novel specific inhibitor of mammalian DNA polymeraseß from the fungus Paecilomyces formosus.EBI
Kobe Gakuin University
Inhibitory effect of novel somatostatin peptide analogues on human cancer cell growth based on the selective inhibition of DNA polymeraseß.EBI
Kobe Gakuin University
Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position.EBI
Kobe Gakuin University
Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design.EBI
Kobe Gakuin University
Hymenoic acid, a novel specific inhibitor of human DNA polymerase lambda from a fungus of Hymenochaetaceae sp.EBI
Kobe Gakuin University
Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platform.EBI
Kobe Gakuin University
Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands.EBI
Kobe Gakuin University
Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonists.EBI
Kobe Gakuin University
Synthesis of 3,6-bis[H-Tyr/H-Dmt-NH(CH2)m,n]-2(1H)pyrazinone derivatives: function of alkyl chain length on opioid activity.EBI
Kobe Gakuin University
Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists.EBI
Kobe Gakuin University
New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motif.EBI
Kobe Gakuin University
Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3).EBI
Kobe Gakuin University
Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2.EBI
Kobe Gakuin University
Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties.EBI
Kobe Gakuin University
Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia.EBI
Kobe Gakuin University
Development of plasmin and plasma kallikrein selective inhibitors and their effect on M1 (melanoma) and HT29 cell lines.EBI
Kobe Gakuin University
Development of a Single-Chain Peptide Agonist of the Relaxin-3 Receptor Using Hydrocarbon Stapling.EBI
Kobe Gakuin University
Structure-activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P(2) position.EBI
Kobe Gakuin University
Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine.EBI
Kobe Gakuin University
Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.BDB
Philipps University Marburg